AU2002332122A1 - Modulation of akt-dependent response to prevent restenosis - Google Patents
Modulation of akt-dependent response to prevent restenosisInfo
- Publication number
- AU2002332122A1 AU2002332122A1 AU2002332122A AU2002332122A AU2002332122A1 AU 2002332122 A1 AU2002332122 A1 AU 2002332122A1 AU 2002332122 A AU2002332122 A AU 2002332122A AU 2002332122 A AU2002332122 A AU 2002332122A AU 2002332122 A1 AU2002332122 A1 AU 2002332122A1
- Authority
- AU
- Australia
- Prior art keywords
- akt
- modulation
- dependent response
- prevent restenosis
- restenosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32880301P | 2001-10-15 | 2001-10-15 | |
US60/328,803 | 2001-10-15 | ||
PCT/US2002/032617 WO2003032809A2 (en) | 2001-10-15 | 2002-10-15 | Modulation of akt-dependent response to prevent restenosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002332122A1 true AU2002332122A1 (en) | 2003-04-28 |
Family
ID=23282509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002332122A Abandoned AU2002332122A1 (en) | 2001-10-15 | 2002-10-15 | Modulation of akt-dependent response to prevent restenosis |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002332122A1 (en) |
WO (1) | WO2003032809A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1311269E (en) | 2000-08-04 | 2012-05-10 | Dmi Biosciences Inc | Method of using diketopiperazines and composition containing them |
JP2007500747A (en) | 2003-05-15 | 2007-01-18 | ディーエムアイ バイオサイエンシズ インコーポレイテッド | Treatment of T cell mediated diseases |
EP2300011A4 (en) | 2008-05-27 | 2012-06-20 | Dmi Life Sciences Inc | Therapeutic methods and compounds |
EP2177510A1 (en) | 2008-10-17 | 2010-04-21 | Universität des Saarlandes | Allosteric protein kinase modulators |
US8614221B2 (en) | 2009-03-11 | 2013-12-24 | Merck Sharp & Dohme Corp. | Inhibitors of Akt activity |
US8691825B2 (en) | 2009-04-01 | 2014-04-08 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
EP2613786A4 (en) | 2010-09-07 | 2013-10-23 | Dmi Acquisition Corp | Treatment of diseases |
EP2755482B1 (en) | 2011-09-15 | 2016-06-01 | Merck Sharp & Dohme Corp. | Combination of mk-1775 and mk-8776 for treating cancer |
CN103841987B (en) | 2011-10-10 | 2015-06-17 | 安皮奥制药股份有限公司 | Treatment of degenerative joint disease |
MY172699A (en) | 2011-10-10 | 2019-12-10 | Ampio Pharmaceuticals Inc | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
EP2771007B1 (en) | 2011-10-28 | 2018-04-04 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
CA2892361A1 (en) | 2012-11-28 | 2014-06-05 | Merck Sharp & Dohme Corp. | Use of a wee1 inhibitor for treating a cancer characterized by low pkmyt1 expression levels |
JP6588005B2 (en) | 2013-03-15 | 2019-10-09 | アンピオ ファーマシューティカルズ,インコーポレイテッド | Pharmaceutical composition used to stimulate cartilage formation |
RU2020136589A (en) | 2014-08-18 | 2020-12-24 | Ампио Фармасьютикалз, Инк. | TREATMENT OF DEGENERATIVE JOINT DISEASES |
WO2016209969A1 (en) | 2015-06-22 | 2016-12-29 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
-
2002
- 2002-10-15 AU AU2002332122A patent/AU2002332122A1/en not_active Abandoned
- 2002-10-15 WO PCT/US2002/032617 patent/WO2003032809A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003032809A3 (en) | 2004-03-18 |
WO2003032809A2 (en) | 2003-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002213467A1 (en) | Modulation of ccr4 function | |
AU2002310593A1 (en) | Laser parrering of devices | |
AU2002255329A1 (en) | Stable solution of reduced coenzyme Q | |
AU2002363005A1 (en) | Derivatives of uk-2a | |
AU2002360375A1 (en) | Synthesis strategies based on the appropriate use of inductance effects | |
AU2002359437A1 (en) | N way phase cancellation power amplifier | |
AU2002355190A1 (en) | Uses of biomaterial substrates | |
AU2002332122A1 (en) | Modulation of akt-dependent response to prevent restenosis | |
AU2002359659A1 (en) | Cross reference to related application | |
AU2002317367A1 (en) | Predistorting of contention signals | |
AU2002304853A1 (en) | Substituted benzopyranones as telomerase inhibitors | |
AU2002342909A1 (en) | Pyrrole synthesis | |
AU2001271426A1 (en) | Modulation of apoptosis | |
AU2002356615A1 (en) | Novel utilization of cyclopentabenzofurans | |
AU2002362273A1 (en) | Polymorphisms of pd-1 | |
AU2002316552A1 (en) | Inhibitor of t cell activation | |
AU2003295790A1 (en) | Modulation of iap-like expression | |
AU2002322551A1 (en) | Antisense modulation of rip2 expression | |
AU2001275063A1 (en) | Regulators of apoptosis | |
AU2003297906A1 (en) | Modulation of interleukin 18 expression | |
AU7711800A (en) | Novel uses of 2-bromopalmitate | |
AU2002367429A1 (en) | Apoptosis inductor | |
AU2003293079A1 (en) | Modulation of jagged 1 expression | |
AU2002329838A1 (en) | Modulation of appl expression | |
AU2002360957A1 (en) | Heterogenisation of catalytic components |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |